Parent Study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA Sub-study)
Clinical trial NCT05648110 · COMPLETED
Trial details
- NCT number
- NCT05648110
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-16
- Primary completion
- 2024-03-29
- Enrollment
- 3882
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.